Utama › Sindrom Mielodisplastik
Kajian klinikal Sindrom Mielodisplastik sedang mengambil peserta di AS
157 kajian untuk Sindrom Mielodisplastik sedang mengambil peserta di lokasi seluruh Amerika Syarikat.
Bandar dengan paling banyak kajian
- Houston, TX43 kajian
- Baldwin Park, CA26 kajian
- New York City, NY21 kajian
- Seattle, WA21 kajian
- Washington, DC20 kajian
- Boston, MA19 kajian
- Tampa, FL19 kajian
- Miami, FL17 kajian
- Columbus, OH14 kajian
- Durham, NC14 kajian
- Chicago, IL13 kajian
- Atlanta, GA13 kajian
- St. Louis, MO13 kajian
- Cleveland, OH11 kajian
- Nashville, TN11 kajian
- Philadelphia, PA10 kajian
- Birmingham, AL10 kajian
- Los Angeles, CA10 kajian
- Mountain View, CA9 kajian
- Pittsburgh, PA9 kajian
- Baltimore, MD9 kajian
- Winston-Salem, NC9 kajian
- Jacksonville, FL9 kajian
- The Bronx, NY9 kajian
- Portland, OR8 kajian
- Buffalo, NY8 kajian
- New Haven, CT8 kajian
- Milwaukee, WI8 kajian
- Minneapolis, MN8 kajian
- Salt Lake City, UT8 kajian
- Memphis, TN7 kajian
- Clifton, NJ7 kajian
- Cedar Rapids, IA7 kajian
- Edison, NJ7 kajian
- Orange, CA7 kajian
- Kansas City, MO7 kajian
- San Francisco, CA6 kajian
- Aurora, CO6 kajian
- Rochester, NY6 kajian
- Queens, NY6 kajian
Mengikut negeri
- Alabama10 kajian
- Arizona9 kajian
- Arkansas4 kajian
- California41 kajian
- Colorado8 kajian
- Connecticut10 kajian
- Florida31 kajian
- Georgia15 kajian
- Hawaii3 kajian
- Idaho4 kajian
- Illinois16 kajian
- Indiana4 kajian
- Iowa7 kajian
- Kansas5 kajian
- Kentucky5 kajian
- Louisiana5 kajian
- Maine4 kajian
- Maryland23 kajian
- Massachusetts21 kajian
- Michigan8 kajian
- Minnesota13 kajian
- Mississippi3 kajian
- Missouri15 kajian
- Montana3 kajian
- Nebraska4 kajian
- Nevada3 kajian
- New Hampshire5 kajian
- New Jersey13 kajian
- New Mexico4 kajian
- New York38 kajian
- North Carolina19 kajian
- North Dakota4 kajian
- Ohio22 kajian
- Oklahoma4 kajian
- Oregon10 kajian
- Pennsylvania17 kajian
- Rhode Island4 kajian
- South Carolina7 kajian
- Tennessee15 kajian
- Texas44 kajian
- Utah8 kajian
- Vermont3 kajian
- Virginia8 kajian
- Washington21 kajian
- West Virginia4 kajian
- Wilayah Columbia4 kajian
- Wisconsin11 kajian
Kajian yang dikemas kini baru-baru ini
Teks kajian rasmi (Bahasa Inggeris)
Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms
Mengambil pesertaFasa 1/2
Umur 12 hingga 120 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06303193Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06577441Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
Mengambil pesertaFasa 1
Umur 18 hingga 120 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06904066Natural History of Trisomy 8-Associated Autoinflammatory Disease (TRIAD) and Related Disorders
Mengambil pesertaKajian pemerhatian
1 Day – 99 Years · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07683104Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06484062Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
Mengambil pesertaFasa 1/2
Umur 4 hingga 75 · Semua jantina · Dikemas kini 1 Okt 2026 · NCT03173937The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07285044A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
Mengambil pesertaFasa 1
Umur 12 hingga 78 · Semua jantina · Dikemas kini 29 Sep 2026 · NCT03802695CHIP/CCUS Natural History Protocol
Mengambil pesertaKajian pemerhatian
Umur 18 hingga 99 · Semua jantina · Dikemas kini 28 Sep 2026 · NCT04102423MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT05564390A Phase 1B/2A Trial of NADUNOLIMAB in Combination With Azacitidine (With/Without Venetoclax) in Patients With Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06548230Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
Mengambil pesertaFasa awal 1
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Sep 2026 · NCT06398457Quizartinib, Decitabine, and Venetoclax in Treating Participants With Untreated or Relapsed Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Sep 2026 · NCT03661307Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT05320198Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
Mengambil pesertaFasa 2
Umur 4 hingga 80 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT01174108Natural History Study of GATA2 Deficiency and Related Disorders
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 2 hingga 100 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT01905826A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Sep 2026 · NCT07422480Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
Mengambil pesertaFasa 1
Umur 1 ke atas · Semua jantina · Dikemas kini 18 Sep 2026 · NCT03630991CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Sep 2026 · NCT04375631Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Sep 2026 · NCT04282187Collection of Tissue Samples for Cancer Research
Mengambil pesertaKajian pemerhatian
2 Months · Semua jantina · Dikemas kini 16 Sep 2026 · NCT00900198Co-Transplant of an Unmodified Haplo-Identical Graft With Cord Blood
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Sep 2026 · NCT06904482Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Sep 2026 · NCT03471260Enasidenib and Azacitidine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia and IDH2 Gene Mutation
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Sep 2026 · NCT03683433A Study of BGB-11417 in Participants With Myeloid Malignancies
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Sep 2026 · NCT04771130Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.